Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Parental burnout and fertility anxiety: The role of parental psychological flexibility and family functioning among mothers.

Journal of family psychology : JFP : journal of the Division of Family Psychology of the American Psychological Association (Division 43)·2026
Same author

The hydra and hormetic effects in a single discrete-time overcompensation model.

Mathematical biosciences·2026
Same author

Association of real-time noise exposure with rest-activity circadian rhythms and sleep health: a 7-day longitudinal measure among Hong Kong nurses with night-shifts.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Integrative multi-omics analysis identifies a robust 14-metabolite signature and reveals microbiome-metabolite-host interactions in atherosclerosis.

Frontiers in cardiovascular medicine·2026
Same author

Computational prediction of TCR cross-reactivity: principles, challenges and translational opportunities.

Journal of translational medicine·2026
Same author

Resistance monitoring and putative biochemical mechanisms of Spodoptera frugiperda to different insecticides in China.

Pest management science·2026

相关实验视频

Updated: Jun 29, 2025

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

17.4K

DOTAD:一个治疗抗体开发能力的数据库.

Wenzhen Li1, Hongyan Lin1, Ziru Huang1

  • 1School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 611731, China.

Interdisciplinary sciences, computational life sciences
|March 26, 2024
PubMed
概括

DOTAD数据库提供了关键的治疗抗体开发能力数据,解决了计算药物发现的关键挑战. 该资源通过提供可访问的数据和分析工具,有助于开发更好的抗体疗法.

关键词:
开发抗体的发展.数据库数据库数据库是一个数据库.开发能力 开发能力治疗性抗体治疗性抗体

更多相关视频

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
04:24

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

1.5K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.8K

相关实验视频

Last Updated: Jun 29, 2025

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

17.4K
Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
04:24

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

1.5K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.8K

科学领域:

  • 生物技术是生物技术.
  • 药物发现 药物发现 药物发现
  • 计算生物学 计算生物学

背景情况:

  • 评估治疗性抗体开发能力对于药物发现至关重要,但在实验上具有挑战性.
  • 计算方法提供了一个有效的替代方案,但需要大量的数据来训练和验证模型.
  • 缺乏可访问的抗体开发能力数据阻碍了计算方法的进步.

研究的目的:

  • 建立第一个专门用于治疗抗体开发能力信息的数据库.
  • 为抗体序列数据和可开发性指标提供一个集中存储库.
  • 促进用于抗体开发能力评估的计算模型的培训和验证.

主要方法:

  • 从科学文献中整理治疗性抗体序列数据.
  • 与序列数据一起汇总各种可开发性指标.
  • 开发一个基于Web的界面,并集成分析工具.

主要成果:

  • 创建了DOTAD,这是第一个专门用于治疗抗体开发能力的数据库.
  • 综合性抗体序列数据和可开发性指标的聚合.
  • 集成先进的计算工具用于数据分析和解释.

结论:

  • DOTAD解决了治疗性抗体可开发性研究中的关键数据缺口.
  • 该数据库是科学界的一个有价值的,免费可访问的资源.
  • DOTAD支持在抗体开发和药物发现方面推进计算方法的进步.